Pharsight

Drug patents revoked in 2023

Drug patents revoked in 2023 at the European Patent Office (EPO).

Patent Number Patent Title Company Revoked Date Oppositions
EP2991637B1 Fenfluramine for use in the treatment of dravet syndrome KATHOLIEKE UNIVERSITEIT LEUVEN Dec, 2023
TEVA PHARMACEUTICAL INDUSTRIES
EP2932970B1 Antiviral therapy VIIV HEALTHCARE Dec, 2023
COOKE
TEVA PHARMACEUTICAL INDUSTRIES
EP2547315B1 Colouring composition for keratin fibres KAO GERMANY GMBH Dec, 2023
(Expiration: Sep, 2030)
HENKEL
EP3614992B1 Antidandruff hair care composition comprising pyrithione UNILEVER GLOBAL IP LTD Dec, 2023
(Expiration: Mar, 2038)
THE PROCTER & GAMBLE
EP2203053B1 Modified starch material of biocompatible hemostasis INDIVIDUAL Dec, 2023
(Expiration: Jan, 2029)
BIOCER ENTWICKLUNGS
HEMOTEC MEDICAL
MAGLE CHEMOSWED HOLDING
EP2347762B1 Exendin for treating diabetes and reducing body weight AMYLIN PHARMACEUTICALS LLC Dec, 2023
(Expiration: Aug, 2026)
GENERICS UK
INSTONE
EP3166572B1 Anti-calculus oral compositions PROCTER AND GAMBLE CO Dec, 2023
(Expiration: Jul, 2034)
TRSCH
EP2893540B1 Rubidium elution system control OTTAWA HEART INSTITUTE RESEARCH CORP Dec, 2023
(Expiration: Oct, 2032)
UEXKLL & STOLBERG PARTNERSCHAFT VON PATENT UND RECHTSANWLTEN MBB
EP3209309B1 Compositions comprising bacterial strains 4D PHARMA RESEARCH LTD Dec, 2023
(Expiration: Nov, 2036)
HOFFMANN EITLE
JANSSEN BIOTECH
EP3241550B1 (1r, 2r)-3-(dimenthyl amino-1-ethyl-2-methyl-propyl) phenol for treating painful inflammations GRUENENTHAL GMBH Dec, 2023
(Expiration: Nov, 2023)
DR SCHN
GENERICS UK
HEXAL
TEVA PHARMACEUTICAL INDUSTRIES
EP1992388B1 Process for colouring hair based on acidic direct dyes KAO GERMANY GMBH Nov, 2023
(Expiration: May, 2025)
LOREAL
EP2609812B1 Liquid nucleotides/nucleosides-containing product NUTRICIA NV Nov, 2023
(Expiration: Mar, 2028)
SOCIT DES PRODUITS NESTL
EP3188717B1 Formulation comprising particles PERORA GMBH Nov, 2023
(Expiration: Aug, 2035)
DSM NUTRITIONAL PRODUCTS
EP3240554B1 Blautia stercosis and wexlerae for use in treating inflammatory and autoimmune diseases 4D PHARMA RESEARCH LTD Nov, 2023
(Expiration: Jun, 2036)
HOFFMANN EITLE
EP2863762B1 Method to convert insects or worms into nutrient streams and compositions obtained thereby BUHLER (CHANGZHOU) INSECT TECHNOLOGIES COLTD Nov, 2023
(Expiration: Jun, 2033)
GEA MECHANICAL EQUIPMENT
NEXTPROTEIN
YNSECT
EP2955180B1 Propane-i-sulfonic acid {3- [5- (4- chloro-phenyl) -1h-pyrrolo [2, 3-b} pyridine-3-carbonyl] -2, 4-difluoro-phenyl} -amide compositions and uses thereof F HOFFMANN LA ROCHE AG Nov, 2023
(Expiration: Mar, 2030)
GENERICS UK
EP3549611B1 Switch costimulatory receptors UNIVERSITY OF PENNSYLVANIA PENN Nov, 2023
(Expiration: Jul, 2032)
OETKE
EP2144613B1 Methods of altering bone growth by administration of sost or wise antagonist or agonist OSTEOQC INC Nov, 2023
(Expiration: Dec, 2027)
UCB BIOPHARMA SPRL
EP3140320B1 Peptide vaccine comprising mutant ras peptide and chemotherapeutic agent TARGOVAX SOLUTIONS Nov, 2023
STRAWMAN
EP3177645B1 Subcutaneously administered bispecific antibodies for use in the treatment of cancer LINDIS BIOTECH GMBH Nov, 2023
(Expiration: Aug, 2035)
ABBVIE
BOEHRINGER INGELHEIM RCV BOEHRINGER INGELHEIM
DR H ULRICH DRRIES
F HOFFMANN LA ROCHE GENENTECH
GENMAB
JAMES POOLE
JANSSEN BIOTECH
LAVA THERAPEUTICS
MORPHOSYS
REGENERON PHARMACEUTICALS
EP3209381B1 Compositions comprising bacterial strains 4D PHARMA RESEARCH LTD Nov, 2023
(Expiration: Nov, 2036)
BRADY
HOFFMAN EITLE PATENT UND RECHTSANWLTE PARTNERSCHAFTSGESELLSCHAFT MBB
EP3459554B1 Yeast extract having diabetes prevention effect KOHJIN LIFE SCIENCES CO LTD Nov, 2023
(Expiration: May, 2037)
STEINBACH
EP3661503B1 Antifungal agents with enhanced activity in acidic ph SCYNEXIS CHEMISTRY AND AUTOMATION INC Nov, 2023
(Expiration: Jul, 2038)
SANDOZ
SYNTHON
EP2983697B1 Treatment of diabetes mellitus by long acting formulations of insulins SANOFI SA Nov, 2023
(Expiration: Apr, 2034)
COOKE
EP3701795B1 Microcapsule and method for producing the same SHIN ETSU CHEMICAL CO LTD Nov, 2023
(Expiration: Feb, 2040)
ARKEMA FRANCE
EP3773457B1 Personal cleansing composition UNILEVER GLOBAL IP LTD Nov, 2023
(Expiration: Jun, 2039)
DALLI WERKE
HENKEL
EP3134123B1 Il-2rbeta-selective agonists in combination with an anti-ctla-4 antibody or an an anti-pd-1 antibody NEKTAR THERAPEUTICS INDIA PVT LTD Nov, 2023
(Expiration: Feb, 2035)
GREINER
EP1771192B1 Use of aspartate for regulating glucose levels in blood NUTRICIA NV Nov, 2023
(Expiration: Jul, 2025)
FRESENIUS KABI DEUTSCHLAND
EP3111954B1 Methods of treating ankylosing spondylitis using anti-il-17 antibodies NOVARTIS AG Nov, 2023
(Expiration: Nov, 2031)
BOULT WADE TENNANT
DR REDDYS LABORATORIES
STRAWMAN
EP3200605B1 Labyrinthulomycetes biomass with high exopolysaccharide- and so4-content and its use in the production of animal feed EVONIK OPERATIONS GMBH Nov, 2023
(Expiration: Oct, 2035)
ABEL & IMRAY
EP2723758B1 Angiopoietin-like 3 (angptl3) irna compostions and methods of use thereof ALNYLAM PHARMACEUTICALS Nov, 2023
GRNECKER PATENT UND RECHTSANWLTE PARTG MBB
EP2934189B1 Human milk oligosaccharides to ameliorate symptoms of stress ABBOTT LABORATORIES Nov, 2023
(Expiration: Dec, 2033)
SOCIT DES PRODUITS NESTL
EP3316878B1 Methods and compounds for the alleviation of pain INDIVIDUAL Nov, 2023
(Expiration: Jun, 2036)
J A KEMP
EP1983984B1 Tuberous sclerosis treatment NOVARTIS AG Oct, 2023
(Expiration: Jan, 2027)
COOKE
INTAS PHARMACEUTICALS
STADA ARZNEIMITTEL
TEVA PHARMACEUTICAL INDUSTRIES
EP2298279B1 Pharmaceutical compositions for inhalation VECTURA LTD Oct, 2023
(Expiration: Nov, 2021)
GLAXO GROUP
EP2421541B1 Novel use CLASADO INC Oct, 2023
(Expiration: Apr, 2030)
NUTRICIA
EP3138916B1 Immunogenic composition GLAXOSMITHKLINE BIOLOGICALS SA Oct, 2023
(Expiration: May, 2032)
VALNEVA AUSTRIA
EP3085386B1 Method for inhibiting bone resorption AMGEN INC Oct, 2023
(Expiration: Sep, 2028)
JAMES POOLE
EP2397155B1 Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (pd-1)pathway DANA FARBER CANCER INSTITUTE Oct, 2023
JANSSEN SCIENCES IRELAND UC
REGENERON PHARMACEUTICALS
SANOFI
EP2563508B1 Delivery particle PROCTER AND GAMBLE CO Oct, 2023
(Expiration: May, 2030)
HENKEL
EP2874630B1 Dosing regimen for janus kinase (jak) inhibitors ZOETIS SERVICES LLC Oct, 2023
(Expiration: Jul, 2033)
KRKA
EP3435985B1 Granulate formulation of 5-methyl-1-phenyl-2(1h)-pyridone and method of making the same F HOFFMANN LA ROCHE AG Oct, 2023
(Expiration: Mar, 2037)
LEDERER & KELLER PATENTANWLTE PARTNERSCHAFT MBB
EP3003485B1 Composition comprising beta-casein a2 for use in the prevention of inflammation of the bowel A2 MILK CO LTD Oct, 2023
(Expiration: May, 2034)
ARLA FOODS AMBA
FRESENIUS KABI DEUTSCHLAND
EP3554461B1 Cosmetic composition comprising solid fatty substances and a gelling polymer LOREAL SA Oct, 2023
(Expiration: Dec, 2037)
BEIERSDORF
HENKEL
RECKITT BENCKISER HEALTH
EP3076967B1 Methods for treating residual symptoms of schizophrenia INTRA CELLULAR THERAPIES INC Oct, 2023
(Expiration: Dec, 2034)
SANDOZ
EP3109258B1 Recombinant rsv antigens GLAXOSMITHKLINE BIOLOGICALS SA Oct, 2023
(Expiration: Dec, 2028)
JANSSEN VACCINES & PREVENTION
PFIZER
EP2289527B1 Bifidobacterium longum and functional GI disorders NESTEC SA Oct, 2023
(Expiration: Aug, 2029)
MORINAGA MILK INDUSTRY
EP3148574B1 Purified compositions of ivig and kh proteins for modulating lymphocytes and treating hepatitis b virus RARE ANTIBODY ANTIGEN SUPPLY INC Oct, 2023
(Expiration: May, 2035)
HOFFMAN EITLE PATENT UND RECHTSANWLTE PARTNERSCHAFTSGESELLSCHAFT MBB
EP2976101B1 Method of treatment GLAXOSMITHKLINE BIOLOGICALS SA Sep, 2023
(Expiration: Mar, 2034)
SANOFI PASTEUR
EP2750707B1 Pegylated liposomes for delivery of immunogen-encoding rna GLAXOSMITHKLINE BIOLOGICALS SA Sep, 2023
(Expiration: Aug, 2032)
MLLER
STRAWMAN
EP3007737B1 Method for crosslinking hyaluronic acid; method for preparing an injectable hydrogel; hydrogel obtained; use of the obtained hydrogel ANTEIS SA Sep, 2023
(Expiration: Jun, 2034)
LABORATOIRES VIVACY
EP3549601B1 Non-lipidated variants of neisseria meningitidis orf2086 antigens WYETH LLC Sep, 2023
(Expiration: Sep, 2031)
JG OPPOSITIONS
EP3294264B1 Composition for keratin fibers LOREAL SA Sep, 2023
(Expiration: May, 2036)
HENKEL
KAO GERMANY
EP3398446B1 Edible composition comprising bifidobacterium longum SOCIETE DES PRODUITS NESTLE SA Sep, 2023
(Expiration: Apr, 2029)
MORINAGA MILK INDUSTRY
EP3072398B1 Bifidobacterium longum and hippocampal bdnf expression NESTEC SA Sep, 2023
(Expiration: Apr, 2029)
MORINAGA MILK INDUSTRY
EP2576578B1 Polymorphs of 2'-o-fucosyllactose and producing thereof GLYCOM AS Sep, 2023
(Expiration: Jun, 2031)
BASF
EP2805723B1 Cladribine regimen for treating multiple sclerosis MERCK SERONO SA Sep, 2023
(Expiration: Dec, 2025)
GENERICS UK
EP2968301B1 Combination of two antivirals for treating hepatitis c ABBVIE INC Sep, 2023
(Expiration: Mar, 2034)
GENERICS UK
EP2754440B1 Medicinal agent for treating amyotrophic lateral sclerosis or preventing progression of phase of amyotrophic lateral sclerosis MITSUBISHI TANABE PHARMA CORP Sep, 2023
(Expiration: Sep, 2032)
MAIWALD PATENT UND RECHTSANWALTSGESELLSCHAFT
EP2661276B1 Topical composition comprising botulinum toxin and a dye REVANCE THERAPEUTICALS INC Aug, 2023
(Expiration: Dec, 2031)
ALLERGAN
EP2696861B1 Combination of epa, dpa and/or dha with a chemotherapeutic agent NUTRICIA NV Aug, 2023
(Expiration: Apr, 2032)
FRESENIUS KABI DEUTSCHLAND
EP3265115B1 Abaloparatide combined with alendronate for reducing non-vertebral bone fractures RADIUS HEALTH INC Aug, 2023
(Expiration: Mar, 2036)
AERA
EP2438903B1 Preservative-free sunscreen BEIERSDORF AG Aug, 2023
(Expiration: Sep, 2031)
DALLI WERKE
LORAL
STADA ARZNEIMITTEL
EP3134084B1 Method of treating lung adenocarcinoma EXELIXIS INC Aug, 2023
(Expiration: Apr, 2035)
GENERICS UK
EP3135275B1 Pharmaceutical composition capable of the incorporation of lenalidomide in various crystalline modifications JSC GRINDEKS Aug, 2023
(Expiration: Aug, 2035)
BACHELIN
HOFFMAN EITLE PATENT UND RECHTSANWLTE PARTNERSCHAFTSGESELLSCHAFT MBB
SYNTHON
EP3351246B8 Rapamycin derivative for the treatment of a solid tumor associated with deregulated angiogenesis NOVARTIS PHARMA AG Jul, 2023
(Expiration: Feb, 2022)
ACCORD HEALTHCARE
ARROW GENERIQUES
BIOGARAN
DR REDDYS LABORATORIES
DR REDDYS LABORATORIES BETAPHARM ARZNEIMITTEL
ETHYPHARM
GENERICS UK
STADA ARZNEIMITTEL
TEVA PHARMACEUTICAL INDUSTRIES
ZENTIVA PHARMA
EP3082711B1 Composition of pickering emulsion comprising low amount of alcohol LOREAL SA Jul, 2023
(Expiration: Dec, 2033)
BEIERSDORF
HENKEL
EP3025719B1 Combination immunotherapy of antigen-recognizing receptors and hematopoietic cells for the treatment of diseases MILTENYI BIOTEC GMBH Jul, 2023
(Expiration: Nov, 2035)
HOFFMANN EITLE
EP1591105B1 Use of antioxidants for the preparation of pharmaceutical or cosmetic compositions for protecting the skin from damages by infrared-radiations STADA ARZNEIMITTEL AG Jul, 2023
(Expiration: Mar, 2025)
DALLI WERKE
DM DROGERIE MARKT
EMIL KIESSLING
MERCK PATENT
MIBELLE
SYMRISE
EP2217230B1 Prevention and treatment of secondary infections following viral infection NESTEC SA Jul, 2023
(Expiration: Nov, 2028)
NUTRICIA
EP2647707B1 Cytotoxicity-inducing therapeutic agent CHUGAI PHARMACEUTICAL CO LTD Jul, 2023
(Expiration: Nov, 2031)
BOEHRINGER INGELHEIM RCV BOEHRINGER INGELHEIM
GENMAB
JAMES POOLE
JANSSEN BIOTECH
MATHYS & SQUIRE
EP2852370B1 Radiance compositions and methods of use JOHNSON AND JOHNSON CONSUMER INC Jul, 2023
(Expiration: May, 2032)
HENKEL
EP2345433B1 Tissue plug 3D MATRIX LTD Jul, 2023
(Expiration: Oct, 2029)
POTTER CLARKSON
EP2818160B1 Enteric coated, low-strength pancrelipase formulations APTALIS PHARMA LTD Jul, 2023
(Expiration: Sep, 2031)
MATHYS & SQUIRE
EP3287123B1 Aqueous pharmaceutical formulation of tapentadol for oral administration GRUENENTHAL GMBH Jul, 2023
(Expiration: Mar, 2032)
LABOMED PHARMACEUTICAL COMPAMY
EP3344289B1 Pestivirus vaccines for congenital tremors BOEHRINGER INGELHEIM VETMEDICA GMBH Jul, 2023
(Expiration: Aug, 2036)
INTERVET
EP2667892B1 Rsv immunization regimen GLAXOSMITHKLINE BIOLOGICALS SA Jul, 2023
(Expiration: Jan, 2032)
PFIZER
EP1832179B1 Carbohydrate composition and flat glucose response NUTRICIA NV Jun, 2023
(Expiration: Dec, 2025)
SOCIT DES PRODUITS NESTL
EP3576711B1 Personal care composition PROCTER AND GAMBLE CO Jun, 2023
(Expiration: Feb, 2038)
EDGEWELL PERSONAL CARE BRANDS
EP1893734B1 Near anhydrous consumer products comprising fragranced aminoplast capsules FIRMENICH SA Jun, 2023
(Expiration: May, 2026)
GIVAUDAN
HENKEL
THE PROCTER & GAMBLE
UNILEVER UNILEVER
EP2616099B1 Immunogenic compositions GLAXOSMITHKLINE BIOLOGICALS SA Jun, 2023
(Expiration: Sep, 2031)
PFIZER
EP3338794B1 Toxicity management for anti-tumor activity of cars CHILDRENS HOSPITAL OF PHILADELPHIA CHOP Jun, 2023
(Expiration: Jul, 2033)
BOULT WADE TENNANT
GEDEON RICHTER PHARMA
HOFFMAN EITLE PATENT UND RECHTSANWLTE PARTNERSCHAFTSGESELLSCHAFT MBB
SECERNA
STRAWMAN
WEINZIERL
ZWICKER SCHNAPPAUF & PARTNER PATENTANWLTE PARTG MBB
EP3265122B1 Combination of pembrolizumab and eribulin for treating triple-negative breast cancer EISAI R&D MANAGEMENT CO LTD Jun, 2023
(Expiration: Mar, 2036)
GENERICS UK
KNIG SZYNKA TILMANN VON RENESSE
PAJARO
WUESTHOFF & WUESTHOFF PATENTANWLTE PARTG MBB
EP3287140B1 Nerve growth factor composition and powder injection BEIJING STAIDSON MEDICAL TECHNOLOGY CO LTD Jun, 2023
(Expiration: Apr, 2036)
DOMP FARMACEUTICI
EP2575775B1 Process for making dry and stable hemostatic compositions BAXTER HEALTHCARE SA Jun, 2023
(Expiration: Jun, 2031)
ETHICON
FERROSAN MEDICAL DEVICES
EP2782584B1 Natural combination hormone replacement formulations and therapies THERAPEUTICSMD INC Jun, 2023
(Expiration: Nov, 2032)
DR SCHN
GENERICS UK
RIECK
EP3036256B1 Modulation of tumor immunity MERCK SHARP AND DOHME LLC Jun, 2023
(Expiration: Aug, 2034)
PAJARO
REGENERON PHARMACEUTICALS
EP3560500B1 Progesterone formulations THERAPEUTICSMD INC Jun, 2023
(Expiration: Jun, 2033)
DR SCHN
RIECK
EP3031907B1 Materials and methods to enhance hematopoietic stem cells engraftment procedures INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORP Jun, 2023
(Expiration: Nov, 2029)
JAMES POOLE
EP2406399B1 Mirac proteins BIOATLA INC Jun, 2023
(Expiration: Mar, 2030)
HOFFMANN EITLE
EP2512425B1 Cleansing composition KAO GERMANY GMBH Jun, 2023
(Expiration: Dec, 2030)
LOREAL
EP2653162B1 Methods of administering fluvoxamine therapy INTERMUNE INC Jun, 2023
(Expiration: Dec, 2030)
AERA
ALFRED E TIEFENBACHER
INTAS PHARMACEUTICALS
SANDOZ
EP2244591B1 A palatable nutritional composition comprising a nucleotide and/or a nucleoside and a taste masking agent NUTRICIA NV Jun, 2023
(Expiration: Dec, 2028)
NESTEC
EP3398444B1 Method to convert insects or worms into nutrient streams and compositions obtained thereby BUEHLER INSECT TECHNOLOGY SOLUTIONS AG May, 2023
(Expiration: Jun, 2033)
GEA WESTFALIA SEPARATOR GROUP
NEXTPROTEIN
YNSECT
EP2809295B1 Composition and association of sunscreens for photostabilizing butyl methoxydibenzoylmethane (bmdbm) PIERRE FABRE DERMO COSMETIQUE SA May, 2023
(Expiration: Jan, 2033)
BEIERSDORF
EP2780374B1 Binding molecules for bcma and cd3 AMGEN RESEARCH MUNICH GMBH May, 2023
(Expiration: Nov, 2032)
JAMES POOLE
JANSSEN BIOTECH
KNIG SZYNKA TILMANN VON RENESSE
MATHYS & SQUIRE
PFIZER
REGENERON PHARMACEUTICALS
SANOFI
EP3436038B1 Beta-caseins and cognitive function A2 MILK CO LTD May, 2023
(Expiration: Mar, 2037)
ARLA FOODS AMBA
FONTERRA OPERATIVE GROUP
NUTRICIA
EP2601341B1 Use of a textile treatment compositon for removal of deodorant stains HENKEL AG AND CO KGAA May, 2023
(Expiration: Jul, 2031)
UNILEVER UNILEVER
EP3492073B1 Oral mucosa application material and method for producing same RITAPHARMA CO LTD May, 2023
(Expiration: Jul, 2037)
CONTIPRO
EP3492109B1 Modified nucleosides, nucleotides, and nucleic acids, and uses thereof MODERNATX INC May, 2023
(Expiration: Oct, 2032)
BIONTECH
SANOFI
EP2802607B1 Dual antigen-induced bipartite functional complementation JULIUS MAXIMILIANS UNIVERSITAET WUERZBURG May, 2023
(Expiration: Jan, 2033)
FHOFFMANN LA ROCHE
REVITOPE
EP2774606B1 Pharmaceutical composition comprising ivabradine hydrochloride polymorph IV SYNTHON BV May, 2023
(Expiration: Feb, 2034)
ALGEMEEN OCTROOI EN MERKENBUREAU
DR SCHN
MAIWALD PATENT UND RECHTSANWALTSGESELLSCHAFT
NEIDLEIN
STRAWMAN
EP3337467B1 Combination therapy using liposomal irinotecan and a parp inhibitor for cancer treatment IPSEN BIOPHARM LTD May, 2023
(Expiration: Aug, 2036)
SANDOZ
EP2792373B1 Ultra high molecular weight polyethylene articles and methods of forming ultra high molecular weight polyethylene articles ZIMMER GMBH May, 2023
(Expiration: Aug, 2025)
AESCULAP
EP3111974B1 Cell preparations for extemporaneous use, useful for healing and rejuvenation in vivo REGEN LAB SA May, 2023
(Expiration: Aug, 2027)
ESTAR
EP3464373B1 Use of anti-pd-1 antibody in the treatment of patients with colorectal cancer BRISTOL MYERS SQUIBB CO Apr, 2023
(Expiration: Jun, 2037)
GREINER
LEDERER & KELLER PATENTANWLTE PARTNERSCHAFT MBB
MAIWALD PATENT UND RECHTSANWALTSGESELLSCHAFT
MICHALSKI HTTERMANN & PARTNER PATENTANWLTE MBB
PAJARO
POHLMAN
EP2496246B1 Composition, method, and kit for alpha-1 proteinase inhibitor GRIFOLS THERAPEUTICS LLC Apr, 2023
(Expiration: Nov, 2030)
EUROPEAN OPPOSITIONS
EP3003277B1 Process for the preparation of a pharmaceutical composition comprising rivaroxaban SANDOZ AG Apr, 2023
(Expiration: May, 2034)
HGF
EP2176357B1 A colouring composition comprising starch derivatives as a hydrocolloid CHR HANSEN NATURAL COLORS AS Apr, 2023
(Expiration: Jul, 2028)
DSM NUTRITIONAL PRODUCTS
SENSIENT COLORS EUROPE
EP2834246B1 Combination products with tyrosine kinase inhibitors and their use NOVARTIS AG Apr, 2023
(Expiration: Apr, 2033)
D YOUNG
EP3171868B1 Packaged acetaminophen injection solution preparation TERUMO CORP Apr, 2023
(Expiration: Jul, 2034)
HOFFMANN EITLE
EP2101731B1 Endoxifen for use in the treatment of cancer JINA PHARMACEUTICALS INC Apr, 2023
(Expiration: Nov, 2027)
BAYER BAYER
BESINS HEALTHCARE MONACO SAM
EP3009143B1 Progranulin for use in treating parkinson's disease or alzheimer's disease NEURODYN LIFE SCIENCES INC Apr, 2023
(Expiration: Jan, 2029)
CMS CAMERON MCKENNA NABARRO OLSWANG
MATHYS & SQUIRE
EP3388048B1 Sunscreen with a reduced tendency to stain textiles iii BEIERSDORF AG Apr, 2023
(Expiration: Apr, 2035)
BASF
EP2968254B1 Methods of treating lung cancer ABRAXIS BIOSCIENCE LLC Mar, 2023
(Expiration: Mar, 2034)
TEVA PHARMACEUTICAL INDUSTRIES
EP3082858B1 Adrenomedullin binder for use in therapy of cancer ANGIOBIOMED GMBH Mar, 2023
(Expiration: Dec, 2034)
SCHIWECK WEINZIERL KOCH PATENTANWLTE PARTNERSCHAFT MBB
EP2729188B1 Compressed gas aerosol dispenser with enhanced intensity and longevity of actives SC JOHNSON AND SON INC Mar, 2023
(Expiration: Jul, 2032)
THE PROCTER & GAMBLE
EP3616680B1 Compound containing basic dye and amino acid, hair dying dye, and hair dying composition HODOGAYA CHEMICAL CO LTD Mar, 2023
(Expiration: Aug, 2039)
HENKEL
EP2292252B1 Unitary combination of FSH and hCG FERRING BV Mar, 2023
(Expiration: Jun, 2024)
MERCK SERONO
EP3247370B1 Water soluble coniferous resin for treating and preventing sterile inflammation REPOLAR PHARMACEUTICALS OY Mar, 2023
(Expiration: Jan, 2036)
BOCO
EP2955190B1 Chemical compounds NUCANA PLC Mar, 2023
(Expiration: Jul, 2024)
GILEAD SCIENCES
EP2992897B1 Immunogenic compositions comprising lawsonia intercellularis BOEHRINGER INGELHEIM VETMEDICA INC Mar, 2023
(Expiration: Mar, 2026)
CEVA SANTE ANIMALE
INTERVET
EP3134065B1 Composition in the form of nano- or micro- emulsion LOREAL SA Mar, 2023
(Expiration: Mar, 2035)
HENKEL
EP1976558B1 Pcv2 immunogenic composition for lessening clinical symptoms in pigs BOEHRINGER INGELHEIM VETMEDICA INC Mar, 2023
(Expiration: Dec, 2026)
ELI LILLY
EP2824181B1 Novel fgfr3 fusion product ASTELLAS PHARMA INC Mar, 2023
(Expiration: Mar, 2033)
BOULT WADE TENNANT
JAMES POOLE
EP2957284B1 Animal pest control method EI DU PONT DE NEMOURS AND CO Mar, 2023
(Expiration: Jun, 2028)
INTERVET
NISSAN CHEMICAL
VIRBAC
EP2482849B1 Combination immunotherapy for the treatment of cancer UNIVERSITY OF TEXAS SYSTEM Mar, 2023
(Expiration: Sep, 2030)
GLAXOSMITHKLINE
KYMAB
EP2356914B1 Composition for improving membrane composition and functioning of cells NUTRICIA NV Mar, 2023
(Expiration: Dec, 2026)
ABBOTT LABORATORIES
SOCIT DES PRODUITS NESTL
EP2453743B1 N-acetyl cysteine compositions and their use in improving the therapeutic efficacy of acetaminophen LELAND STANFORD JUNIOR UNIVERSITY Mar, 2023
(Expiration: Jul, 2030)
PRFER & PARTNER MBB
EP3377049B1 Crystalline forms of tapentadol salts and process for preparation thereof MSN LABORATORIES PVT LTD Mar, 2023
(Expiration: Nov, 2036)
URQUHART DYKES & LORD
EP2772249B1 Method and composition for treating ocular hypertension and glaucoma ASAHI GLASS CO LTD Mar, 2023
(Expiration: May, 2029)
COOKE
EP2484383B1 Method for improving the aqueous solubility of poorly-soluble substances SANGI CO LTD Mar, 2023
(Expiration: Sep, 2030)
OMYA
EP2633867B1 Vaccine for protection against lawsonia intracellularis, mycoplasma hyopneumoniae and porcine circo virus INTERVET INTERNATIONAL BV Feb, 2023
(Expiration: Apr, 2029)
BOEHRINGER INGELHEIM VETMEDICA
CEVA SANTE ANIMALE
EP3003316B1 Combination therapies for cancer GLAXOSMITHKLINE LLC Feb, 2023
(Expiration: May, 2034)
PAJARO
EP3204022B1 Placenta-derived adherent cell exosomes and uses thereof CELULARITY INC Feb, 2023
(Expiration: Oct, 2035)
D YOUNG
EP3574914B1 Corticosteroid compositions VIROPHARMA BIOLOGICS LLC Feb, 2023
(Expiration: Nov, 2028)
DR FALK PHARMA
EP2782588B1 Methods and compositions for the treatment of diabetes and related symptoms EMMAUS MEDICAL INC Feb, 2023
(Expiration: Nov, 2032)
JAMES POOLE
EP2575776B1 Process for making dry and stable hemostatic compositions BAXTER HEALTHCARE SA Feb, 2023
(Expiration: Jun, 2031)
ETHICON
FERROSAN MEDICAL DEVICES
EP2486806B1 Stevia composition PURECIRCLE USA INC Feb, 2023
(Expiration: Aug, 2031)
SAGITTARIUS CONSULTANTS
EP2512422B1 Conditioning composition for hair KAO GERMANY GMBH Feb, 2023
(Expiration: Dec, 2030)
HENKEL
EP2545939B1 Tetrahydrobiopterin for treating conditions associated with elevated phenylalanine levels BIOMARIN PHARMACEUTICAL INC Feb, 2023
(Expiration: Apr, 2028)
BETAPHARM ARZNEIMITTEL
CORIPHARMA EHF
DIPHARMA
STADA ARZNEIMITTEL
TEVA PHARMACEUTICAL INDUSTRIES
EP3470432B1 Methods for treating or preventing asthma by administering an il-4r antagonist SANOFI BIOTECHNOLOGY SAS Feb, 2023
(Expiration: Aug, 2033)
DR H ULRICH DRRIES
D YOUNG
NEUEFEIND
SECERNA
EP2451462B1 Inhibiting inflammation with milk oligosaccharides INSTITUTO NACIONAL DE CIENCIAS MEDICAS Y NUTRICION Feb, 2023
(Expiration: Jul, 2030)
GRNECKER PATENT UND RECHTSANWLTE PARTG MBB
NUTRICIA
EP2280687B1 Chewing gum compositions comprising cannabinoids STICHTING SANAMMAD Feb, 2023
(Expiration: Mar, 2029)
MEDCAN PHARMA
EP3138853B1 Fc variants with altered binding to fcrn XENCOR INC Feb, 2023
(Expiration: Sep, 2028)
COHAUSZ & FLORACK PATENT UND RECHTSANWLTE PARTNERSCHAFTSGESELLSCHAFT MBB
EP1827604B1 Methods and compositions for adoptive immunotherapy PETER MACCALLUM CANCER INSTITUTE Feb, 2023
(Expiration: Dec, 2025)
GLAXOSMITHKLINE
MATHYS & SQUIRE
PATENT BOUTIQUE
EP2207597B1 Light inhibitors for asthma, lung and airway inflammation, respiratory, interstitial, pulmonary and fibrotic disease treatment LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY Feb, 2023
(Expiration: Sep, 2028)
EUROPEAN OPPOSITIONS
EP3113749B1 Abrasive skin cleaning products ii BEIERSDORF AG Feb, 2023
(Expiration: Feb, 2035)
DALLI WERKE
HENKEL
EP2977372B1 Polymorphs of febuxostat SANDOZ AG Jan, 2023
(Expiration: Jun, 2031)
ALFRED E TIEFENBACHER
EP3522921B1 Prevention of allergy ASIT BIOTECH SA Jan, 2023
(Expiration: Oct, 2037)
NUTRICIA
EP2793833B1 Topical oil composition for the treatment of fungal infections VYOME THERAPEUTICS LTD Jan, 2023
(Expiration: Dec, 2032)
BEIERSDORF
HENKEL
THE PROCTER & GAMBLE
EP3253382B1 Pharmaceutical compositions for combination therapy INTERCEPT PHARMACEUTICALS INC Jan, 2023
(Expiration: Feb, 2036)
STADA ARZNEIMITTEL
EP2673262B1 Processes for preparing quinoline compounds and pharmaceutical compositions containing such compounds EXELIXIS INC Jan, 2023
(Expiration: Feb, 2032)
STADA ARZNEIMITTEL
EP2750704B1 Synthetic capsid proteins and uses thereof CEVA SANTE ANIMALE SA Jan, 2023
(Expiration: Aug, 2032)
MERIAL
EP3188709B1 Transparent cosmetic and personal care compositions UNILEVER PLC Jan, 2023
(Expiration: Aug, 2035)
HENKEL
EP3270951B1 Botulinum neurotoxin-specific capture agents, compositions, and methods of using and making CALIFORNIA INSTITUTE OF TECHNOLOGY CALTECH Jan, 2023
(Expiration: Mar, 2036)
MERZ PHARMA
EP2477611B1 (z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluormethylphenyl)-amide tablet formulations with improved stability SANOFI SA Jan, 2023
(Expiration: Sep, 2030)
COOKE
PENTAFARMA SOCIEDADE TCNICO MEDICINAL
WUESTHOFF & WUESTHOFF PATENTANWLTE PARTG MBB